Paper17525162
Intranuclear protein transduction through a nucleoside salvage pathway.
Hansen JE and 5 others. J Biol Chem, 2007. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Intranuclear protein transduction through a nucleoside salvage pathway. Papers, record 17525162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17525162
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation | Major topic |
| Nucleotides | Major topic |
| Active Transport, Cell Nucleus | |
| Animals | |
| Autoimmune Diseases | |
| Biological Transport | |
| COS Cells | |
| Cell Membrane | |
| Cell Nucleus | |
| Chlorocebus aethiops | |
| Humans | |
| K562 Cells | |
| Models, Biological | |
| Nucleosides | |
| Protein Transport |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41465139 | Chromosomal Instability and Telomere Attrition in Systemic Sclerosis: A Historical Perspective. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41465139 | PubMed |
| 41127334 | Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/41127334 | PubMed |
| 41077566 | Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41077566 | PubMed |
| 40668891 | Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer. | Sci Transl Med | 2025 | https://conductscience.org/library/papers/40668891 | PubMed |
| 40313010 | Cytoplasmic delivery of antibodies through grafting a functional single complementarity-determining region loop. | FEBS Lett | 2025 | https://conductscience.org/library/papers/40313010 | PubMed |
| 40132052 | A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells. | Sci Signal | 2025 | https://conductscience.org/library/papers/40132052 | PubMed |
| 39352803 | Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition. | Oncotarget | 2024 | https://conductscience.org/library/papers/39352803 | PubMed |
| 39277505 | Neurological glycogen storage diseases and emerging therapeutics. | Neurotherapeutics | 2024 | https://conductscience.org/library/papers/39277505 | PubMed |
| 39220699 | Cathepsin B Nuclear Flux in a DNA-Guided "Antinuclear Missile" Cancer Therapy. | ACS Cent Sci | 2024 | https://conductscience.org/library/papers/39220699 | PubMed |
| 38433835 | IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease. | Front Immunol | 2024 | https://conductscience.org/library/papers/38433835 | PubMed |
| 38318190 | Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies. | Front Immunol | 2024 | https://conductscience.org/library/papers/38318190 | PubMed |
| 37554056 | The multifaceted roles of the brain glycogen. | J Neurochem | 2024 | https://conductscience.org/library/papers/37554056 | PubMed |
| 37171750 | Cellular protection from H2O2 toxicity by Fv-Hsp70: protection via catalase and gamma-glutamyl-cysteine synthase. | Cell Stress Chaperones | 2023 | https://conductscience.org/library/papers/37171750 | PubMed |
| 35401191 | Bispecific Antibodies Progression in Malignant Melanoma. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35401191 | PubMed |
| 34128837 | ENT2 facilitates brain endothelial cell penetration and blood-brain barrier transport by a tumor-targeting anti-DNA autoantibody. | JCI Insight | 2021 | https://conductscience.org/library/papers/34128837 | PubMed |
| 33602551 | 251st ENMC international workshop: Polyglucosan storage myopathies 13-15 December 2019, Hoofddorp, the Netherlands. | Neuromuscul Disord | 2021 | https://conductscience.org/library/papers/33602551 | PubMed |
| 32962155 | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder. | Biomolecules | 2020 | https://conductscience.org/library/papers/32962155 | PubMed |
| 31522955 | Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases. | Trends Mol Med | 2019 | https://conductscience.org/library/papers/31522955 | PubMed |
| 31353261 | Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion. | Cell Metab | 2019 | https://conductscience.org/library/papers/31353261 | PubMed |
| 31329461 | Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease. | Mol Pharm | 2019 | https://conductscience.org/library/papers/31329461 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC29A2 | 3177 | PubTator's text mining | https://conductscience.org/library/genes/3177 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17525162
GET https://conductscience.org/api/papers/v1/17525162/cited_by?page=2